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Abstract: Treatment-as-prevention is a term used to describe an HIV prevention method that uses antiretroviral
treatment to minimize the chance of HIV transmission, with the idea that treatment can decrease the viral load of those
infected to a level where transmission risk is minimal. However, for treatment-as-prevention to be a success, individuals
must get tested, know their status, seek care, and adhere to their antiretroviral regimen. Communication plays a role in
each of these steps, as communication can be used to create demand for health-seeking behavior and as a means to
increase quality and support on the supply side, at the clinic and community level. From the demand side,
communication has played a role in convincing people to get tested and obtain their results, in ensuring treatment
access, linking those infected to care, and addressing stigmatizing attitudes that may prevent individuals from taking
these actions. On the supply side, communication has been shown to mobilize community care and support and
increase the quality of patient-provider interaction, which in turn can improve adherence. Finally, communication has
played an integral role in structural issues related to treatment-as-prevention, including the assurance of adequate
supplies, including HIV testing kits, anti-retrovirals, and condoms.

Keywords: Treatment, prevention, communication.
Public health efforts to reduce the spread of
HIV/AIDS are undergoing a major shift, from the ABCs
for sexual transmission (abstinence, being faithful, and
condom use) and avoidance of shared injection
equipment for parenteral transmission, to an increased
emphasis on biomedical approaches. These include
the use of antiretroviral (ARV) drugs for pre- and postexposure prophylaxis. Treatment-as-prevention, the
notion that treatment of HIV-positive individuals with
ARVs radically reduces their infectiousness, with
potentially large population-level implications for
reductions in incidence, is increasingly being embraced
as a promising approach in ending the epidemic [1-3].
Numerous investigators have argued for the
potential contributions of the social and behavioral
sciences for maximizing the impact of treatment-asprevention [4-8]. Realizing the full potential of
treatment-as-prevention requires achieving viral load
suppression in the largest possible proportion of HIV
infected individuals. This, in turn, entails several
sequential requirements: the so-called “cascade of HIV
care” [9]. HIV infected individuals must be identified
through testing; once diagnosed, they must be linked to
and retained in care that includes viral load and CD4
monitoring. When appropriate, they must be given
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ARVs; they must adhere to the greatest possible extent
to their ARV regimens; and those regimens must be
adapted as necessary in response to side effects and
inadequate viral control. Unfortunately, there are
decrements at every step in this process. Not all HIV
infected individuals get tested, not all of those who
learn their status are linked to care, and so on [1, 9,
10]. Different impediments operate at each stage of the
cascade, and one way to classify the stages in the
cascade is through a supply and demand lens. The
impediments to the cascade occur on both the supply
and demand sides: critical infrastructure must be
established and maintained to ensure an adequate
supply of testing kits, medications, and human
resources, while at the same time, individuals must be
persuaded to get tested, to remain in care, and to
adhere to ARV regimens.
In the context of the AIDS epidemic, communication
is an essential part of any comprehensive program that
includes both services (medical, social, psychological
and spiritual) and commodities (condoms, needles and
syringes). Before individuals and communities can
reduce their level of risk or change their behaviors, they
must first understand basic facts about HIV/AIDS,
adopt key attitudes, learn the necessary skills to reduce
risk of exposure and be given access to appropriate
products and services. They must also perceive their
environment as supporting safer behaviors, as well as
supportive of seeking appropriate treatment for
© 2013 Synergy Publishers
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prevention, care and support. In this paper we focus on
the specific roles that communication science can play
in bolstering treatment-as-prevention on both the
supply and demand sides and at several steps along
the cascade of HIV care.
THE DEMAND SIDE
Communication interventions can play important
roles in generating demand for HIV testing. These
interventions take a variety of forms (mass media,
community or individually oriented), and can focus on a
variety of messages about who should get tested (risk
perception), why testing is important (motivation), what
to expect (fear reduction) and where to find testing
services (increased efficacy). Exposure to campaigns
addressing these informational needs in various
countries has been significantly associated with
increases in HIV testing [11, 12]. Communication
interventions have also played an integral role in
decreasing stigma [13-15], a major barrier to testing in
many countries [16, 17]. Specifically among married
men or men in long-term relationships, fear of partner
abandonment, loss of social status and workplace
discrimination [17], for example, can all too easily deter
individuals from learning their status.
Communication interventions can also play an
essential demand-side role at other steps of the HIV
care cascade. A communication campaign in Uganda
provided adult caregivers with critical information on
accessing treatment and caring for HIV positive
children [18]. In Malawi and Ethiopia, radio diaries
featuring PLHAs have been used effectively to share
experiences on coping with treatment challenges [14].
Additionally, enhanced patient-provider communication
has shown to have positive impacts on patient health
behavior, as it can result in greater patient satisfaction,
adherence to treatment plans, and improved health
outcomes, such as higher health status, emotional
health, and symptom relief [19]. Communication
interventions can increase the quality of interpersonal
communication between the patient and health
professional, a factor proven to be of critical importance
in ART adherence from both the patient and health
professional perspective [20].
At the community level, once a diagnosis of
HIV/AIDS has been made and treatment has been
initiated, the community takes a major responsibility in
providing a continuum of care and support [21].
Communication interventions in the form of community
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mobilization can encourage frequent interpersonal
communication with household members as well as
religious and traditional leaders, and by providing
counseling to those infected and affected, community
health workers invariably increase community
awareness, which in turn can reduce stigma and
increase the uptake of service utilization [22].
Communication interventions can play a valuable role
in sensitization and subsequent involvement in
HIV/AIDS awareness and education of not only health
personnel, traditional healers and traditional birth
attendants, but other key community members
normally not involved in health issues such as political,
community
and
religious
leaders,
teachers,
associations, and other representatives of key
grassroots community groups [23, 24].
THE SUPPLY SIDE
Demand-generation interventions may have little
effect, however, or may even be counterproductive, if
they cause spikes in demand that outstrip supply. This
happened recently in Malawi due to an inadequate
supply of HIV testing kits [25]. Similarly, problems with
the supply of ARVs have been a major impediment to
treatment-as-prevention in numerous countries [26-28].
In Malawi, the dependence on one ARVs supplier has
led to an absence of buffer stock, and the lack of the
existence of a reliable system that has the ability to
offer treatment to greater numbers of infected people
has impacted ART uptake [28]. In Cote d’Ivoire, facilitylevel stock
outs
have influenced
treatment
discontinuation [27]. In areas where physicians are
scarce – such as Mozambique, DRC, India, and
Myanmar – expanded access to ARVs is further
constrained because nurses and other non-physician
health workers are not allowed to initiate ART [26]. In
many countries (Cameroon, DRC, CAR, Guinea,
Mozambique, Myanmar and Lesotho), policies do not
allow for multi-month ART refills [26].
Expanding access to ARVs is dependent upon
leadership at the country level. A form of
communication – advocacy – comprises collective
action to make resource allocations to support the
expansion of medicines, testing and prevention [29]. In
countries where there is poor access to health care,
low spending on health, and political instability,
advocacy is a critical component to guarantee the
resources necessary to sufficiently address the
epidemic [30]. Advocacy can play a key role in
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expanding access to ARVs by facilitating or demanding
the development and implementation of policies that
would allow and encourage non-physicians in
community health clinics to offer ART services as well
as provide multi-month ART refills.
In addition, advocacy can push for targeting priority
populations for scale-up, such as serodiscordant
couples, MSM, pregnant women, and those with CD4
counts of less than 350 [31]. HIV advocacy can also be
utilized to build the political will necessary to ensure
financial, technical and human resources required for
treatment-as-prevention to work [26, 28]. Brazil’s
success in providing free and universal ARV access,
during a time when experts recommended that
resource-poor countries focus on prevention instead of
treatment, highlights the lead role played by statebased organizations in advocating for appropriate
policies regarding medicine supply as well as the
importance of constructing alliances [32].
Although considered a promising approach in
ending the epidemic, treatment-as-prevention presents
a number of challenges, including resource constraints,
logistical hurdles, emergence of drug-resistant viral
strains, adherence to therapy regimens, and risk
compensation [33]. We suggest that communication is
important and relevant at all stages in the continuum,
and scientists, health care providers, policy makers,
and communities should harness the power of
communication to fully realize the individual and public
health benefits of treatment-as-prevention. In this
broader context, we urge the public health community
to think about treatment drugs not as the magic bullet
for prevention, but rather as a key component that,
when combined with sound communication practices,
can play a significant role in reducing new infections.
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